Healthcare provider profile · identity verified

Rebecca Lynn Wright, D.O.

General Practice · CHICKASHA, OK · NPI 1801183249

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	321	43
Atorvastatin Calcium	Atorvastatin Calcium	316	47
Amlodipine Besylate	Amlodipine Besylate	293	50
Furosemide	Furosemide	289	45
Potassium Chloride	Potassium Chloride	249	50
Lisinopril	Lisinopril	225	43
Donepezil Hcl	Donepezil Hcl	214	37
Omeprazole	Omeprazole	193	32
Trazodone Hcl	Trazodone Hcl	180	34
Buspirone Hcl	Buspirone Hcl	172	33
Gabapentin	Gabapentin	170	35
Eliquis	Apixaban	165	25
Memantine Hcl	Memantine Hcl	161	30
Sertraline Hcl	Sertraline Hcl	160	24
Citalopram Hbr	Citalopram Hydrobromide	156	31
Tamsulosin Hcl	Tamsulosin Hcl	137	24
Metoprolol Tartrate	Metoprolol Tartrate	136	23
Simvastatin	Simvastatin	112	16
Carvedilol	Carvedilol	109	19
Xarelto	Rivaroxaban	100	suppressed
Losartan Potassium	Losartan Potassium	99	24
Pantoprazole Sodium	Pantoprazole Sodium	98	24
Metoprolol Succinate	Metoprolol Succinate	87	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	86	15
Trulicity	Dulaglutide	83	11
Famotidine	Famotidine	80	13
Quetiapine Fumarate	Quetiapine Fumarate	74	14
Clopidogrel	Clopidogrel Bisulfate	71	16
Pravastatin Sodium	Pravastatin Sodium	68	suppressed
Metformin Hcl	Metformin Hcl	67	11
Duloxetine Hcl	Duloxetine Hcl	64	suppressed
Meloxicam	Meloxicam	62	13
Finasteride	Finasteride	61	suppressed
Tramadol Hcl	Tramadol Hcl	61	20
Olanzapine	Olanzapine	60	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	57	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	57	suppressed
Glipizide	Glipizide	57	suppressed
Montelukast Sodium	Montelukast Sodium	57	suppressed
Risperidone	Risperidone	52	14
Pioglitazone Hcl	Pioglitazone Hcl	50	suppressed
Alendronate Sodium	Alendronate Sodium	45	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	39	suppressed
Latanoprost	Latanoprost	37	suppressed
Mirtazapine	Mirtazapine	37	11
Humalog Kwikpen U-100	Insulin Lispro	36	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	30
Spironolactone	Spironolactone	34	suppressed
Divalproex Sodium	Divalproex Sodium	31	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Atenolol	Atenolol	27	suppressed
Gemtesa	Vibegron	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Nystatin	Nystatin	26	11
Clonidine	Clonidine	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Digoxin	Digoxin	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Nystop	Nystatin	22	14
Lorazepam	Lorazepam	21	12
Naproxen	Naproxen	21	suppressed
Timolol Maleate	Timolol Maleate	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	11
Cyproheptadine Hcl	Cyproheptadine Hcl	20	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	20	suppressed
Benztropine Mesylate	Benztropine Mesylate	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Loperamide	Loperamide Hcl	18	12
Ozempic	Semaglutide	18	suppressed
Torsemide	Torsemide	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Ondansetron Odt	Ondansetron	16	14
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Alprazolam	Alprazolam	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Tobramycin	Tobramycin	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error